锆-89标记利妥昔单抗PET-CT在眼眶炎性疾病中的应用
该回顾性研究评估了89Zr-利妥昔单抗PET/CT在难治性眼眶炎症诊断与治疗管理中的潜在价值。结论认为该技术有望检测眼眶及眼附属器B细胞介导疾病并预测利妥昔单抗疗效。
要点
- 89Zr-利妥昔单抗PET/CT可显示眼眶炎症中B细胞介导的局灶性摄取。
- 阳性扫描后4例(1例TED、3例IOI)对利妥昔单抗治疗反应良好。
- 该扫描曾对1例视神经脑膜瘤的诊断起到关键作用。
核心结论
- 89Zr-利妥昔单抗PET/CT有潜力成为检测眼眶及眼附属器B细胞介导疾病的有力工具,并可能预测难治性炎症患者的利妥昔单抗治疗反应。
主要发现
- 4例(1例TED、3例IOI)在扫描阳性后对利妥昔单抗治疗反应良好。
- 89Zr-利妥昔单抗PET/CT对1例患者视神经脑膜瘤的诊断至关重要。
临床怎么用
- 对于难治性眼眶炎症患者,可考虑行89Zr-利妥昔单抗PET/CT以检测B细胞介导的病灶并辅助预测利妥昔单抗治疗反应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Orbital inflammatory diseases are a heterogenic group of conditions that often entail a difficult diagnostic process and many patients are treatment resistant. Inflammatory diseases can be visualized by Zirconium-89-labelled rituximab PET-CT (89Zr-rituximab PET/CT). In this study, we describe our experience and possible potential of the 89Zr-rituximab PET/CT for diagnostic and therapeutic management of refractory orbital inflammation. RESULTS: Retrospectively, 89Zr-rituximab uptake was assessed and related to clinical data. The main outcome measures were the characteristics of the scan and the clinical relation of uptake with the diagnostic process and treatment effectivity. Twelve patients with thyroid eye disease (TED) and suspected idiopathic orbital inflammation (IOI) were scanned. Six patients had a strong 89Zr-rituximab uptake and showed a focal distribution within the lesion. Four patients (one TED, three IOI) responded well to rituximab treatment after a positive scan. 89Zr-rituximab PET/CT was essential to the diagnosis of optic nerve meningioma in one patient. CONCLUSION: 89Zr-rituximab PET/CT has the potential to be a powerful tool for the detection of B cell-mediated disease within the orbit and ocular adnexa. This technique can be a valuable addition for diagnosing diseases around the eye and can potentially predict rituximab treatment response in patients with refractory inflammation.
引用
- Laban KG, Kalmann R, Leguit RJ, et al. Zirconium-89-labelled rituximab PET-CT in orbital inflammatory disease. EJNMMI Res. 2019. PMID: 31363937. doi:10.1186/s13550-019-0530-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。